Lamees Saud Alrasheed

Ms. Lamees Saud Alrasheed

Medicinal Chemistry, King Saud University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TWTanveer A. Wani
Tanveer A. Wani
SZSeema Zargar
Seema Zargar
HAHamad Alkahtani
Hamad Alkahtani
NANojood Altawijry
Nojood Altawijry
LALamees Saud Alrasheed
Lamees Saud Alrasheed
Several kinds of anticancer drugs are presently commercially accessible, but low efficacy, solubility, and toxicity have reduced the overall therapeutic indices. Thus, the search for promising anticancer drugs continues. The interactions of numerous essential anticancer drugs with DNA are crucial to their biological functions. Here, the anticancer effects of N-ethyl toluene-4-sulphonamide (8a) and 2,5-Dichlorothiophene-3-sulphonamide (8b) on cell lines from breast and cervical cancer were investigated. The study also compared how these substances interacted with the hearing sperm DNA. The most promising anticancer drug was identified as 2,5-Dichlorothiophene-3-sulfonamide (8b), which showed GI50 of 7.2 ± 1.12 µM, 4.62 ± 0.13 µM and 7.13 ± 0.13 µM against HeLa, MDA-MB231 and MCF-7 cells, respectively. Moreover, it also exhibited significant electrostatic and non-electrostatic contributions to the binding free energy. The work utilized computational techniques, such as molecular docking and molecular dynamic (MD) simulations, to demonstrate the strong cytotoxicity of 2,5-Dichlorothiophene-3-sulfamide (8b) in comparison to standard Doxorubicin and cisplatin, respectively. Molecular docking experiments provided additional support for a role for the minor groove in the binding of the 2,5-Dichlorothiophene-3-sulfamide (8b)-DNA complex. The molecular docking studies and MD simulation showed that both compounds revealed comparable inhibitory potential against standard Doxorubicin and cisplatin. This study has the potential to lead to the discovery of new bioactive compounds for use in cancer treatment, including metallic and non-metallic derivatives of 2,5-Dichlorothiophene-3-sulfonamide (8b). It also emphasizes the worth of computational approaches in the development of new drugs and lays the groundwork for future research.

Verified
Journal Article
Open access
PDF file
TWTanveer A. Wani
Tanveer A. Wani
ABAhmed H. Bakheit
Ahmed H. Bakheit
SZSeema Zargar
Seema Zargar
NANojood Altawijry
Nojood Altawijry
Mashooq Ahmad BhatMashooq Ahmad Bhat
Mashooq Ahmad Bhat
LALamees Saud Alrasheed
Lamees Saud Alrasheed
The presence of the p-aryl/cyclohexyl ring in the N-(4-aryl/cyclohexyl)-2-(pyridine-4-yl carbonyl) hydrazine carbothioamide derivative (2C) is reported to enhance the antifungal properties when compared to those of itraconazole. Serum albumins present in plasma bind and transport ligands, including pharmaceuticals. This study explored 2C interactions with BSA using spectroscopic methods such as fluorescence and UV-visible spectroscopy. In order to acquire a deeper comprehension of how BSA interacts with binding pockets, a molecular docking study was carried out. The fluorescence of BSA was quenched by 2C via a static quenching mechanism since a decrease in quenching constants was observed from 1.27 × 105 to 1.14 × 105. Thermodynamic parameters indicated hydrogen and van der Waals forces responsible for the BSA–2C complex formation with binding constants ranging between 2.91 × 105 and 1.29 × 105, which suggest a strong binding interaction. Site marker studies displayed that 2C binds to BSA’s subdomains IIA and IIIA. Molecular docking studies were conducted to further comprehend the molecular mechanism of the BSA–2C interaction. The toxicity of 2C was predicted by Derek Nexus software. Human and mammalian carcinogenicity and skin sensitivity predictions were associated with a reasoning level of equivocal, inferring 2C to be a potential drug candidate.

5 November 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
FAFatmah A. M. Al-Omary
Fatmah A. M. Al-Omary
NGNikhila Chowdary Gude
Nikhila Chowdary Gude
LALamees Saud Alrasheed
Lamees Saud Alrasheed
HAHamad Alkahtani
Hamad Alkahtani
HHHanan M. Hassan
Hanan M. Hassan
STSubbiah Thamotharan
Subbiah Thamotharan
A detailed exploration of crystal packing of two adamantane-isothiourea hybrid derivatives along with a known closely related structure has been performed to delineate the effect of halogen substituents and the role of weak intermolecular interactions in their supramolecular architectures. The adamantane-isothiourea hybrid derivatives used in the present study are (Z)-3-(Adamantan-1-yl)-S-(4-bromobenzyl)-1-phenylisothiourea (1), C24H27BrN2S and (Z)-3-(Adamantan-1-yl)-S-(4-bromobenzyl)-1-(3-chlorophenyl)isothiourea (2), C24H26BrClN2S, characterized by X-ray crystallography. The X-ray structures revealed that the molecular conformation of 1 and 2 are different and stabilized by intramolecular C–H···N interactions. In addition, a short intramolecular H···H contact is formed in 2. The Hirshfeld surface analysis was used to delineate the nature of different intermolecular interactions and their contributions toward crystal packing. The quantitative analysis of strengths of molecular dimers existed in 1 and 2 has been performed using the PIXEL method. The electrostatic potential map clearly revealed nature and strength of σ-holes at Br and Cl atoms. The topological analysis was used to characterize the nature and the strength of various intermolecular interactions including the type I Br···Br contact. Interestingly, all the H–H bonding observed in 1 and 2 show closed-shell in nature. Further, an in-vitro antimicrobial activity studies suggest that the title compounds exhibited potent antibacterial activity against all the tested Gram-positive bacterial strains and Gram-negative Escherichia coli. Compound 2 showed marked anti-proliferative activity against MCF-7 and HeLa cell lines. Communicated by Ramaswamy H. Sarma

1 October 2016 in Zeitschrift für Kristallographie - New Crystal Structures
Verified
Journal Article
Open access
PDF file
FAFatmah A. M. Al-Omary
Fatmah A. M. Al-Omary
LALamees Saud Alrasheed
Lamees Saud Alrasheed
HGHazem A. Ghabbour
Hazem A. Ghabbour
AEAli El-Emam
Ali El-Emam

26 April 2023 in Crystals
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Almehizia
Abdulrahman Almehizia
HAHamad Alkahtani
Hamad Alkahtani
Mohamed A. Al-OmarMohamed A. Al-Omar
Mohamed A. Al-Omar
AOAhmad Jomah Obaidullah
Ahmad Jomah Obaidullah
Mashooq Ahmad BhatMashooq Ahmad Bhat
Mashooq Ahmad Bhat
kareem Abdel-Hafiz Aslakareem Abdel-Hafiz Asla
kareem Abdel-Hafiz Asla
Eight polymer-metal complexes were synthesized from complexation of divalent Mn(II), Ni(II), Co(II), and Cu(II) metal ions with modified polystyrene-alt-(maleic anhydride) (PSMAP and PSMAM) ligands. The structures of these new complexes were characterized using a variety of techniques, including magnetic moment susceptibility, conductance measurements, FT-IR spectroscopy, ultraviolet-visible (UV-VIS), thermogravimetric analysis (TGA), as well as scanning electron microscopy (SEM). All metal-polymer complexes have a non-electrolytic nature based on conductance measurements. The polymer molecule behaves as neutral bidentate NO ligand through O atoms of carbonyl (C=O) and N atoms of amide (O=C-NH). Divalent Mn2+, Ni2+, Co2+ and Cu2+ complexes have an octahedral geometry based on their electronic spectra and magnetic values. Based on thermal analysis data, those new complexes are more thermally stable than the ligands. SEM and TEM are manipulated to give the surface structure and the particle size measurements where they give different shapes and sizes of the synthesized complexes.

23 March 2017 in Zeitschrift für Kristallographie - New Crystal Structures
Verified
Journal Article
Open access
PDF file
AEAli El-Emam
Ali El-Emam
FAFatmah A. M. Al-Omary
Fatmah A. M. Al-Omary
LALamees Saud Alrasheed
Lamees Saud Alrasheed
HGHazem A. Ghabbour
Hazem A. Ghabbour
EAEbtehal S. Al-Abdullah
Ebtehal S. Al-Abdullah
C24H27ClN2S, triclinic P1̅ (no. 2), a = 7.1670(3) Å, b = 12.2734(6) Å, c = 13.1560(6) Å, α = 109.605(2)°, β = 96.515(2)°, γ = 97.312(2)°, V = 1066.08(8) Å3, Z = 2, Rgt(F) = 0.0515, wR ref(F 2) = 0.1396, T = 296(2) K.